BVS
BVS
NASDAQ · Health Care

Bioventus Inc - A

$10.50
-0.15 (-1.41%)
As of May 16, 1:48 AM ET ·
Financial Highlights (FY 2026)
Revenue
695.82M
Net Income
27.85M
Gross Margin
68.3%
Profit Margin
4.0%
Rev Growth
+3.5%
D/E Ratio
1.65
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 68.3% 68.3% 45.6% 45.6%
Operating Margin 9.4% 8.5% 15.0% 14.8%
Profit Margin 4.0% 3.8% 14.9% 11.5%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 695.82M 672.16M 241.82M 197.18M
Gross Profit 475.45M 459.28M 110.34M 89.97M
Operating Income 65.69M 57.11M 36.38M 29.11M
Net Income 27.85M 24.21M 36.10M 22.67M
Gross Margin 68.3% 68.3% 45.6% 45.6%
Operating Margin 9.4% 8.5% 15.0% 14.8%
Profit Margin 4.0% 3.8% 14.9% 11.5%
Rev Growth +3.5% +3.5% -4.8% -2.4%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 275.86M 275.86M 254.88M 304.50M
Total Equity 167.29M 167.29M 321.56M 308.93M
D/E Ratio 1.65 1.65 0.79 0.99
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA 69.34M 63.64M 52.99M 46.00M
Free Cash Flow 25.01M 12.86M